Along with several other drugmakers, Novartis has bet that lowering Lp(a) will cut the risk of sometimes fatal cardiovascular events.
Related stories
Deloitte Romania expands management team with three new directors
Oracle’s stock gets a boost as the OpenAI ecosystem comes back into favor
Cathie Wood Just Went Bargain Hunting. Here Are the 3 AI Stocks She Bought.
Prediction: Oracle's $638 Billion Cloud Infrastructure Backlog Could Make It One of the Best-Performing AI Stocks Through 2028
Flipkart begins internal food delivery pilot in Bengaluru, India
Saffery expands client development team with two new appointments